The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure
Open accessAbstract
Objective: Shortage of organ donors, a critical challenge for treatment of end-stage organ failure, has motivated the development of alternative strategies to generate organs in vitro. Here, we aim to describe the hepatorganoids, which is a liver tissue model generated by three-dimensional (3D) bioprinting of HepaRG cells and investigate its liver functions in vitro and in vivo. Design: 3D bioprinted hepatorganoids (3DP-HOs) were constructed using HepaRG cells and bioink, according to specific 3D printing procedures. Liver functions of 3DP-HOs were detected after 7 days of differentiation in vitro, which were later transplanted into Fah-deficient mice. The in vivo liver functions of 3DP-HOs were evaluated by survival time and liver damage of mice, human liver function markers and human-specific debrisoquine metabolite production. Results: 3DP-HOs broadly acquired liver functions, such as ALBUMIN secretion, drug metabolism and glycogen storage after 7 days of differentiation. After transplantation into abdominal cavity of Fah -/- Rag2 -/- mouse model of liver injury, 3DP-HOs further matured and displayed increased synthesis of liver-specific proteins. Particularly, the mice acquired human-specific drug metabolism activities. Functional vascular systems were also formed in transplanted 3DP-HOs, further enhancing the material transport and liver functions of 3DP-HOs. Most importantly, transplantation of 3DP-HOs significantly improved the survival of mice. Conclusions: Our results demonstrated a comprehensive proof of principle, which indicated that 3DP-HO model of liver tissues possessed in vivo hepatic functions and alleviated liver failure after transplantation, suggesting that 3D bioprinting could be used to generate human liver tissues as the alternative transplantation donors for treatment of liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
Self-citationIn vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
An estimation of the number of cells in the human body
Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., Pelleri, M. C., Tassani, S., Piva, F., et al. (2013) · Annals of Human Biology · doi:10.3109/03014460.2013.807878 · Cited by 1,012
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864
Self-citationLong-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Hu, H., Gehart, H., Artegiani, B., LÖpez-Iglesias, C., Dekkers, F., Basak, O., van Es, J., Chuva de Sousa Lopes, S. M., Begthel, H., Korving, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.013 · Cited by 837
Grompe, M., al-Dhalimy, M., Finegold, M., Ou, C. N., Burlingame, T., Kennaway, N. G., & Soriano, P. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2298 · Cited by 355
In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity
Zhang, K., Zhang, L., Liu, W., Ma, X., Cen, J., Sun, Z., Wang, C., Feng, S., Zhang, Z., Yue, L., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.018 · Cited by 252
Self-citationNovel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro
Leite, S. B., Roosens, T., El Taghdouini, A., Mannaerts, I., Smout, A. J., Najimi, M., Sokal, E., Noor, F., Chesne, C., & van Grunsven, L. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.026 · Cited by 234
Fu, G.-B., Huang, W.-J., Zeng, M., Zhou, X., Wu, H.-P., Liu, C.-C., Wu, H., Weng, J., Zhang, H.-D., Cai, Y.-C., et al. (2019) · Cell Research · doi:10.1038/s41422-018-0103-x · Cited by 167
Self-citation
Research works printed but not linked: 22
- Fisher, 2017, Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?, Nat Rev Gastroenterol Hepatol, 14, 373, 10.1038/nrgastro.2017.2 · DOI
- Tanaka, 2017, Resection versus transplantation for hepatocellular carcinoma exceeding Milan criteria within increasing donor shortage, Hepatobiliary Surg Nutr, 6, 280, 10.21037/hbsn.2017.03.14 · DOI
- Vijayavenkataraman, 2018, 3D bioprinting of tissues and organs for regenerative medicine, Adv Drug Deliv Rev, 132, 296, 10.1016/j.addr.2018.07.004 · DOI · Paper page
- Bernal, 2015, Acute-On-Chronic liver failure, Lancet, 386, 1576, 10.1016/S0140-6736(15)00309-8 · DOI · Paper page
- 10.1016/j.stem.2014.01.003 · DOI · Paper page
- 10.1002/hep.21704 · DOI · Paper page
- 10.1073/pnas.1524510113 · DOI · Paper page
- 10.1073/pnas.232137699 · DOI · Paper page
- 10.1016/j.tiv.2012.05.008 · DOI · Paper page
- Ouyang, 2016, Effect of bioink properties on printability and cell viability for 3D bioplotting of embryonic stem cells, Biofabrication, 8, 10.1088/1758-5090/8/3/035020 · DOI · Paper page
- Li, 2017, Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications, Biofabrication, 9, 10.1088/1758-5090/aa7e9a · DOI
- Swaminathan, 2019, Bioprinting of 3D breast epithelial spheroids for human cancer models, Biofabrication, 11, 10.1088/1758-5090/aafc49 · DOI
- Meng, 2019, 3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments, Adv Mater, 31, 1806899, 10.1002/adma.201806899 · DOI · Paper page
- Hiller, 2018, Generation of a 3D liver model comprising human extracellular matrix in an Alginate/Gelatin-Based Bioink by extrusion Bioprinting for infection and transduction studies, Int J Mol Sci, 19, 10.3390/ijms19103129 · DOI
- Zhao, 2015, The influence of printing parameters on cell survival rate and printability in microextrusion-based 3D cell printing technology, Biofabrication, 7, 10.1088/1758-5090/7/4/045002 · DOI · Paper page
- Pang, 2017, TGF- β induced epithelial–mesenchymal transition in an advanced cervical tumor model by 3D printing, Biofabrication, 10, 10.1088/1758-5090/aadbde · DOI
- Rebelo, 2015, Heparg microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism, Arch Toxicol, 89, 1347, 10.1007/s00204-014-1320-9 · DOI
- 10.1038/ng0396-266 · DOI · Paper page
- Mandrycky, 2016, 3D bioprinting for engineering complex tissues, Biotechnol Adv, 34, 422, 10.1016/j.biotechadv.2015.12.011 · DOI · Paper page
- 10.1126/science.aav9750 · DOI · Paper page
- 10.1089/ten.teb.2009.0085 · DOI · Paper page
- 10.1016/j.tiv.2006.06.003 · DOI · Paper page
Cited by
Zhang, Y. S., Haghiashtiani, G., Hübscher, T., Kelly, D. J., Lee, J. M., Lutolf, M., McAlpine, M. C., Yeong, W. Y., Zenobi-Wong, M., & Malda, J. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00073-8 · Cited by 391
Organoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R., Dai, Y., Hu, Y., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 266
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Xie, F., Sun, L., Pang, Y., Xu, G., Jin, B., Xu, H., Lu, X., Xu, Y., Du, S., Wang, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120416 · Cited by 147
Self-citationCuvellier, M., Ezan, F., Oliveira, H., Rose, S., Fricain, J.-C., Langouët, S., Legagneux, V., & Baffet, G. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120611 · Cited by 126
Chen, X., Wu, T., Bu, Y., Yan, H., & Lin, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147810 · Cited by 88
Metadata
- Authors
- Yang, H., Sun, L., Pang, Y., Hu, D., Xu, H., Mao, S., Peng, W., Wang, Y., Xu, Y., Zheng, Y.-C., Du, S., Zhao, H., Chi, T., Lu, X., Sang, X., Zhong, S., Wang, X., Zhang, H., Huang, P., Sun, W., & Mao, Y.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2020-05-20
- Volume
- 70
- Issue
- 3
- Pages
- 567-574
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W3026731970
- Cited by
- 201
- References
- 10
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. https://app.cochat.ai/papers/10.1136/gutjnl-2019-319960
- The paper
- Yang, H., Sun, L., Pang, Y., Hu, D., Xu, H., Mao, S., Peng, W., Wang, Y., Xu, Y., Zheng, Y.-C., Du, S., Zhao, H., Chi, T., Lu, X., Sang, X., Zhong, S., Wang, X., Zhang, H., Huang, P., . . . Mao, Y. (2021). Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut. https://doi.org/10.1136/gutjnl-2019-319960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
